期刊文献+

卵巢癌细胞培养上清诱导CD4^+CD25^-T细胞分化为CD4^+CD25^+调节性T细胞 被引量:5

Conversion of peripheral CD4^+CD25^- naīve T cells to CD4^+CD25^+ regulatory T cells by ovarian carcinoma cell supernatants
原文传递
导出
摘要 目的研究卵巢癌细胞培养上清液是否能诱导外周血CD4+CD25-T细胞转变为CD4+CD25+调节性T细胞。方法将外周血CD4+CD25-T细胞分离后,对照组用CD3和CD28单抗活化,实验组在对照基础上加用卵巢癌细胞株SKOV3培养上清,72h后分离各组的CD25+和CD25-T细胞,溴化脱氧尿嘧啶掺入标记法测定增殖能力及对静息的自体同源CD4+CD25-T细胞的增殖抑制能力,流式细胞仪测定细胞糖皮质激素诱发型TNF受体(glucocorticoid-induced TNFR,GITR)与CTLA-4分子的表达,RT-PCR检测细胞Foxp3mRNA的表达。结果与对照组相反,实验组的CD4+CD25+T细胞具有免疫抑制功能,自身增殖能力下降,GITR和CTLA-4分子的表达和CD4+CD25+调节性T细胞相似,并被诱导表达转录因子Foxp3mRNA。结论卵巢癌细胞分泌的可溶性物质能诱导外周血CD4+CD25-T细胞转化为CD4+CD25+调节性T细胞。 Objective To investigate whether the supematant from cultured ovarian carcinoma cell line SKOV3 could convert peripheral CD4^+CD25^- T cells into CD4^+CD25^+ regulatory T cells. MethodsCD4^+CD25^- T cells isolated from the peripheral blood of healthy woman were activated with plate-bound anti-CD3 and anti-CD28, which were used as the control group. The supematant of cultured ovarian carcinoma cell line was added to the activated cells as the experiment group. After 72 h, the cells of both groups were harvested separately and further sub-populated into CD25^- and CD25^+ T cells. 1he eel] proliferation was determined by BrdU labelling. Expressions of glucocorticoid-induced TNFR (G1TR) and CILA-4 were tested by flow cytometry. Foxp3 mRNA expression was examined by RT-PCR. Results In contrast to the activated CD4^+CD25^+ T cells, the supernatant-induced CD25^+ T cells which exhibited reduced proliferation capacity and possessed immunosuppressive activity. The supernatant-induced CD25^+ T cells expressed Foxp3 mRNA, GITR and CILA-4. Couclusion The supemarant derived from SKOV3 converts CD4^+CD25^- T cells into CD4^+CD25^+ regulatory T cells, which is probably responsible for the increasing number of CD4^+CD25^ + regulatory T cells in patients with ovarian carcinorna.
出处 《中华微生物学和免疫学杂志》 CAS CSCD 北大核心 2006年第2期121-124,共4页 Chinese Journal of Microbiology and Immunology
关键词 卵巢癌 CD4^+CD25^-调节性T细胞 CTLA-4 G1TR FOXP3 Ovarian carcinoma CD4^+CD25^+ regulatory T cells CILA-4 GITR Foxp3
  • 相关文献

参考文献7

  • 1Itoh M,Takahashi T,Sakaguchi N,et al.Thymus and autoimmunity:production of CD25^ + CD4 ^+ naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance.J Immunol,1999,162(9):5317-5326.
  • 2Woo EY,Chu CS,Golez TJ,et al.Regulatory CD4^ + CD25^ + T cells in tumors from patients with early-stage non-small cell lung cancer and latestage ovarian cancer.Cancer Res,2001,61(12):4766-4772.
  • 3Li X,Ye DF,Xie X,et al.Increase of CD4 ^+ CD25^ + regulatory T cell in the patients with ovarian carcinoma.Cancer Invest,2005,23 (5):399-403.
  • 4Apostolou I,Sarukhan A,Klein L,et al.Origin of regulatory T cells with known specificity for antigen.Nat Immunol,2002,3(8):756-763.
  • 5Levings MK,Sangregorio R,Sartirana C,et al.Human CD25^ + CD4^ + T suppressor cell clones produce transforming growth,but not interleukin 10,and are distinct from type 1 T regulatory cells.J Exp Med,2002,196(10):1335-1346.
  • 6Fontenot JD,Gavin MA,Rudensky AY.Foxp3 programs the development and function of CD4 ^+ CD25 ^+ regulatory T cells.Nat Immunol,2003,4(4):330-336.
  • 7Hori S,Nomura T,Sakaguchi S.Control of regulatory T cell development by the transcription factor Foxp3.Science,2003,299 (5609):1057-1061.

同被引文献46

引证文献5

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部